The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 3,225 | 718,272 | SH | SOLE | 718,272 | 0 | 0 | ||
ACTINIUM PHARMACEUTICALS INC | COM | 00507W107 | 192 | 333,000 | SH | SOLE | 333,000 | 0 | 0 | ||
ADAMIS PHARMACEUTICALS CORP | COM NEW | 00547W208 | 127 | 24,401 | SH | SOLE | 24,401 | 0 | 0 | ||
ADVAXIS INC | COM NEW | 007624208 | 1,032 | 247,000 | SH | SOLE | 247,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 1,723 | 349,592 | SH | SOLE | 349,592 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 5,675 | 116,770 | SH | SOLE | 116,770 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 2,670 | 135,738 | SH | SOLE | 135,738 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 4,239 | 346,013 | SH | SOLE | 346,013 | 0 | 0 | ||
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 1,663 | 421,000 | SH | SOLE | 421,000 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 1,129 | 79,542 | SH | SOLE | 79,542 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 1,822 | 325,409 | SH | SOLE | 325,409 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 904 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
ARQULE INC | COM | 04269E107 | 475 | 427,478 | SH | SOLE | 427,478 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 2,618 | 72,226 | SH | SOLE | 72,226 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 8,593 | 384,145 | SH | SOLE | 384,145 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 7,433 | 71,849 | SH | SOLE | 71,849 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 231 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 6,253 | 1,193,228 | SH | SOLE | 1,193,228 | 0 | 0 | ||
BIOTELEMETRY INC | COM | 090672106 | 1,650 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 618 | 4,500 | SH | SOLE | 4,500 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 5,295 | 76,000 | SH | SOLE | 76,000 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 1,284 | 93,800 | SH | SOLE | 93,800 | 0 | 0 | ||
CASCADIAN THERAPEUTICS INC | COM NEW | 14740B606 | 480 | 117,310 | SH | SOLE | 117,310 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 1,689 | 208,458 | SH | SOLE | 208,458 | 0 | 0 | ||
CLEMENTIA PHARMACEUTICALS IN | COM | 185575107 | 1,013 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
COGENTIX MEDICAL INC | COM | 19243A104 | 828 | 323,482 | SH | SOLE | 323,482 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 3,506 | 435,000 | SH | SOLE | 435,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 107 | 5,900 | SH | SOLE | 5,900 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 380 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 2,039 | 75,500 | SH | SOLE | 75,500 | 0 | 0 | ||
DERMIRA INC | NOTE 3.000% 5/1 | 24983LAA2 | 1,624 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 2,813 | 57,500 | SH | SOLE | 57,500 | 0 | 0 | ||
DEXCOM INC | DBCV 0.750% 5/1 | 252131AE7 | 223 | 250,000 | PRN | SOLE | 250,000 | 0 | 0 | ||
EDGE THERAPEUTICS INC | COM | 279870109 | 208 | 19,400 | SH | SOLE | 19,400 | 0 | 0 | ||
EXACTECH INC | COM | 30064E109 | 907 | 27,532 | SH | SOLE | 27,532 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 1,436 | 258,667 | SH | SOLE | 258,667 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 3,216 | 31,609 | SH | SOLE | 31,609 | 0 | 0 | ||
GALENA BIOPHARMA INC | COM NEW | 363256504 | 16 | 46,145 | SH | SOLE | 46,145 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 6,437 | 460,451 | SH | SOLE | 460,451 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | NOTE 5.750% 8/0 | 45780VAB8 | 461 | 600,000 | PRN | SOLE | 600,000 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 3,166 | 57,484 | SH | SOLE | 57,484 | 0 | 0 | ||
INSULET CORP | NOTE 2.000% 6/1 | 45784PAD3 | 2,814 | 2,250,000 | PRN | SOLE | 2,250,000 | 0 | 0 | ||
INTEC PHARMA LTD JERUSALEM | SHS | M53644016 | 126 | 14,100 | SH | SOLE | 14,100 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | DBCV 2.250% 6/1 | 46333XAD0 | 682 | 573,000 | PRN | SOLE | 573,000 | 0 | 0 | ||
ISHARES TR NASDQ BIOTECH | ETF | 464287556 | 2,902 | 8,700 | SH | SOLE | 8,700 | 0 | 0 | ||
JOHNSON AND JOHNSON | COM | 478160104 | 1,222 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
KADMON HOLDINGS INC | COM | 48283N106 | 419 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 1,583 | 105,859 | SH | SOLE | 105,859 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 24,147 | 262,121 | SH | SOLE | 262,121 | 0 | 0 | ||
LUMINEX CORP DEL | COM | 55027E102 | 508 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 2,850 | 154,200 | SH | SOLE | 154,200 | 0 | 0 | ||
MASIMO CORPORATION | COM | 574795100 | 433 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
MINERVA NEUROSCIENCES INC | COM | 603380106 | 1,300 | 171,094 | SH | SOLE | 171,094 | 0 | 0 | ||
NATUS MEDICAL INC DEL | COM | 639050103 | 296 | 7,900 | SH | SOLE | 7,900 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 252 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 3,340 | 54,508 | SH | SOLE | 54,508 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 1,476 | 37,938 | SH | SOLE | 37,938 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 5,965 | 216,119 | SH | SOLE | 216,119 | 0 | 0 | ||
OBSEVA SA | COM | H5861P103 | 700 | 86,000 | SH | SOLE | 86,000 | 0 | 0 | ||
OPHTHOTECH CORP | COM | 683745103 | 141 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | NOTE 4.500% 9/1 | 74365AAB7 | 2,125 | 2,500,000 | PRN | SOLE | 2,500,000 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 2,055 | 53,309 | SH | SOLE | 53,309 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 4,000 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 1,126 | 443,478 | SH | SOLE | 443,478 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 1,222 | 506,900 | SH | SOLE | 506,900 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM | 82640U107 | 68 | 44,000 | SH | SOLE | 44,000 | 0 | 0 | ||
SPRING BANK PHARMACEUTICALS | COM | 849431101 | 110 | 6,507 | SH | SOLE | 6,507 | 0 | 0 | ||
STEREOTAXIS INC | COM | 85916J409 | 1,126 | 1,372,862 | SH | SOLE | 1,372,862 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 1,613 | 831,332 | SH | SOLE | 831,332 | 0 | 0 | ||
UNIQURE N V | SHS | N90064101 | 1,683 | 175,307 | SH | SOLE | 175,307 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 2,414 | 117,259 | SH | SOLE | 117,259 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,114 | 377,695 | SH | SOLE | 377,695 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 1,840 | 52,500 | SH | SOLE | 52,500 | 0 | 0 |